388 related articles for article (PubMed ID: 22092994)
1. The RANKL-OPG system in clinical periodontology.
Belibasakis GN; Bostanci N
J Clin Periodontol; 2012 Mar; 39(3):239-48. PubMed ID: 22092994
[TBL] [Abstract][Full Text] [Related]
2. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
3. Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis.
Baltacıoğlu E; Kehribar MA; Yuva P; Alver A; Atagün OS; Karabulut E; Akalın FA
J Periodontol; 2014 Feb; 85(2):317-26. PubMed ID: 23701481
[TBL] [Abstract][Full Text] [Related]
4. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
5. Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid.
Bostanci N; Saygan B; Emingil G; Atilla G; Belibasakis GN
J Clin Periodontol; 2011 May; 38(5):428-33. PubMed ID: 21261673
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
Giannopoulou C; Martinelli-Klay CP; Lombardi T
Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
[TBL] [Abstract][Full Text] [Related]
7. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients.
Lappin DF; Sherrabeh S; Jenkins WM; Macpherson LM
J Clin Periodontol; 2007 Apr; 34(4):271-7. PubMed ID: 17378883
[TBL] [Abstract][Full Text] [Related]
8. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.
Wara-aswapati N; Surarit R; Chayasadom A; Boch JA; Pitiphat W
J Periodontol; 2007 Jun; 78(6):1062-9. PubMed ID: 17539720
[TBL] [Abstract][Full Text] [Related]
9. Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid.
Tang TH; Fitzsimmons TR; Bartold PM
J Clin Periodontol; 2009 Sep; 36(9):713-8. PubMed ID: 19570104
[TBL] [Abstract][Full Text] [Related]
10. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients.
Buduneli N; Biyikoğlu B; Sherrabeh S; Lappin DF
J Clin Periodontol; 2008 Oct; 35(10):846-52. PubMed ID: 18727653
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin levels in peri-implant crevicular fluid.
Arikan F; Buduneli N; Kütükçüler N
Clin Oral Implants Res; 2008 Mar; 19(3):283-8. PubMed ID: 18081868
[TBL] [Abstract][Full Text] [Related]
12. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.
Gümüş P; Buduneli E; Bıyıkoğlu B; Aksu K; Saraç F; Nile C; Lappin D; Buduneli N
J Periodontol; 2013 Nov; 84(11):1627-37. PubMed ID: 23327689
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
[TBL] [Abstract][Full Text] [Related]
14. Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid.
López Roldán A; García Giménez JL; Alpiste Illueca F
PLoS One; 2020; 15(1):e0227757. PubMed ID: 31986169
[TBL] [Abstract][Full Text] [Related]
15. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies.
Taubman MA; Kawai T; Han X
J Clin Periodontol; 2007 May; 34(5):367-9. PubMed ID: 17448041
[TBL] [Abstract][Full Text] [Related]
16. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease.
Nagasawa T; Kiji M; Yashiro R; Hormdee D; Lu H; Kunze M; Suda T; Koshy G; Kobayashi H; Oda S; Nitta H; Ishikawa I
Periodontol 2000; 2007; 43():65-84. PubMed ID: 17214836
[No Abstract] [Full Text] [Related]
17. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
Mogi M; Otogoto J; Ota N; Togari A
J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
[TBL] [Abstract][Full Text] [Related]
18. C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study.
Arikan F; Buduneli N; Lappin DF
Int J Oral Maxillofac Implants; 2011; 26(2):282-9. PubMed ID: 21483881
[TBL] [Abstract][Full Text] [Related]
19. Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro.
Nishijima Y; Yamaguchi M; Kojima T; Aihara N; Nakajima R; Kasai K
Orthod Craniofac Res; 2006 May; 9(2):63-70. PubMed ID: 16764680
[TBL] [Abstract][Full Text] [Related]
20. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA
Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
